Ryan Specialty (NYSE:RYAN) Stock Rating Reaffirmed by JMP Securities

Ryan Specialty logo with Finance background

JMP Securities reissued their market perform rating on shares of Ryan Specialty (NYSE:RYAN - Free Report) in a research report released on Monday morning, Benzinga reports.

RYAN has been the subject of several other reports. JPMorgan Chase & Co. raised their target price on shares of Ryan Specialty from $47.00 to $49.00 and gave the stock an underweight rating in a report on Monday, April 8th. Wells Fargo & Company raised their target price on shares of Ryan Specialty from $57.00 to $58.00 and gave the stock an overweight rating in a report on Thursday. Citigroup raised their target price on shares of Ryan Specialty from $49.00 to $52.00 and gave the stock a neutral rating in a report on Wednesday, February 28th. Finally, Keefe, Bruyette & Woods raised their target price on shares of Ryan Specialty from $56.00 to $62.00 and gave the stock an outperform rating in a report on Wednesday, April 10th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and four have assigned a buy rating to the stock. According to MarketBeat, Ryan Specialty presently has a consensus rating of Hold and an average price target of $54.25.

Read Our Latest Stock Report on RYAN


Ryan Specialty Price Performance

Shares of NYSE:RYAN traded down $0.42 during trading hours on Monday, hitting $49.53. 607,990 shares of the company's stock traded hands, compared to its average volume of 753,205. Ryan Specialty has a 52 week low of $39.44 and a 52 week high of $56.51. The company has a debt-to-equity ratio of 1.98, a quick ratio of 1.16 and a current ratio of 1.16. The company's fifty day simple moving average is $50.96 and its two-hundred day simple moving average is $46.81. The company has a market cap of $12.89 billion, a price-to-earnings ratio of 97.12 and a beta of 0.52.

Ryan Specialty (NYSE:RYAN - Get Free Report) last announced its earnings results on Tuesday, February 27th. The company reported $0.35 EPS for the quarter, hitting the consensus estimate of $0.35. Ryan Specialty had a net margin of 9.36% and a return on equity of 44.84%. The company had revenue of $532.90 million during the quarter, compared to analysts' expectations of $524.08 million. During the same period last year, the company posted $0.27 earnings per share. The business's revenue for the quarter was up 22.5% on a year-over-year basis. As a group, equities analysts anticipate that Ryan Specialty will post 1.77 EPS for the current fiscal year.

Ryan Specialty Dividend Announcement

The firm also recently declared a None dividend, which was paid on Wednesday, March 27th. Shareholders of record on Wednesday, March 13th were paid a dividend of $0.34 per share. The ex-dividend date was Tuesday, March 12th. Ryan Specialty's dividend payout ratio is currently 86.28%.

Institutional Investors Weigh In On Ryan Specialty

Institutional investors have recently bought and sold shares of the business. California Public Employees Retirement System acquired a new stake in shares of Ryan Specialty in the 3rd quarter valued at $5,041,000. American Century Companies Inc. boosted its stake in shares of Ryan Specialty by 17.7% in the 3rd quarter. American Century Companies Inc. now owns 1,624,944 shares of the company's stock valued at $78,647,000 after purchasing an additional 244,490 shares in the last quarter. Boston Partners acquired a new stake in shares of Ryan Specialty in the 3rd quarter valued at $50,090,000. Algert Global LLC acquired a new stake in shares of Ryan Specialty in the 3rd quarter valued at $1,706,000. Finally, UBS Group AG boosted its stake in shares of Ryan Specialty by 134.9% in the 3rd quarter. UBS Group AG now owns 138,413 shares of the company's stock valued at $6,699,000 after purchasing an additional 79,478 shares in the last quarter. Institutional investors and hedge funds own 84.82% of the company's stock.

About Ryan Specialty

(Get Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

See Also

Analyst Recommendations for Ryan Specialty (NYSE:RYAN)

Should you invest $1,000 in Ryan Specialty right now?

Before you consider Ryan Specialty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.

While Ryan Specialty currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Featured Articles and Offers

Search Headlines: